— Know what they know.
Not Investment Advice

VREOF OTC

Vireo Growth Inc.
1W: -15.7% 1M: -12.1% 3M: -2.7% YTD: +1475.1%
$9.49
-0.36 (-3.65%)
 
Weekly Expected Move ±12.6%
$7 $8 $9 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $363.0M mcap · 19M float · 0.253% daily turnover · Short 21% of daily vol

Income Trends

Revenue
$269M +170.4% ▲
Gross Profit
$127M +150.3% ▲
Operating Income
$10M -25.1% ▼
Net Income
-$68M -143.2% ▼
EPS (Diluted)
$-0.09 +41.1% ▲
EBITDA
$12M -30.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2025
Revenue$0$0$30M$49M$269M
YoY Growth+0.0%+0.0%+0.0%+64.3%+170.4%
Cost of Revenue$0$0$19M$31M$142M
Gross Profit$0$0$11M$18M$127M
Gross Margin——36.2%36.8%47.3%
R&D Expenses$0$0$0$0$0
SG&A Expenses$84K$139K$28M$26M$100M
Operating Expenses-$84K-$139K$30M$40M$117M
Operating Income-$84K-$139K-$19M-$23M$10M
Operating Margin——-63.6%-46.8%3.8%
Interest Expense$0$0$5M$5M$30M
Income Before Tax-$84K-$139K-$57M-$14M-$40M
Tax Expense$0$0-$299K-$7M$28M
Net Income-$84K-$139K-$57M-$7M-$68M
Net Margin——-190.3%-13.7%-25.3%
EPS (Diluted)$-0.22$-0.37$-0.71$-0.08$-0.09
EBITDA-$84K-$139K-$48M-$8M$12M
Shares Outstanding38017738017781M81M735M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms